Vincristine is an effective therapeutic approach for transplantation-associated thrombotic microangiopathy.
Mateos
J
J
Pérez-Simón
J A
JA
Caballero
D
D
Castilla
C
C
Lopez
O
O
Perez
E
E
Cañizo
C
C
Vazquez
L
L
San Miguel
J F
JF
D000293:Adolescent; D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage*; D002648:Child; D005260:Female; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000150:complications / Q000628:therapy; D008297:Male; D008875:Middle Aged; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects; D012189:Retrospective Studies; D013921:Thrombocytopenia / Q000188:drug therapy* / Q000209:etiology; D014182:Transplantation, Autologous; D014750:Vincristine / Q000008:administration & dosage*
D000972:Antineoplastic Agents, Phytogenic; D014750:Vincristine